Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients. - Wikidata - awgldk - TriplyDB

Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients.

Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients.

http://www.wikidata.org/entity/Q42720362

about

Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain Monoclonal antibody therapies for the treatment of relapsing-remitting multiple sclerosis: differentiating mechanisms and clinical outcomes New insights on human polyomavirus JC and pathogenesis of progressive multifocal leukoencephalopathy JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?The importance of mouse models to define immunovirologic determinants of progressive multifocal leukoencephalopathy Progressive Multifocal Leukoencephalopathy-Associated Mutations in the JC Polyomavirus Capsid Disrupt Lactoseries Tetrasaccharide c Binding In Vitro and In Vivo Models for the Study of Human Polyomavirus Infection JC Polyomavirus Abundance and Distribution in Progressive Multifocal Leukoencephalopathy (PML) Brain Tissue Implicates Myelin Sheath in Intracerebral Dissemination of Infection The trichodysplasia spinulosa-associated polyomavirus: virological background and clinical implications.Viral miRNAs in plasma and urine divulge JC polyomavirus infection.A cornucopia of human polyomaviruses.Polyomavirus JC in the context of immunosuppression: a series of adaptive, DNA replication-driven recombination events in the development of progressive multifocal leukoencephalopathy.Detection of JC virus-specific immune responses in a novel humanized mouse model Immunological Markers for PML Prediction in MS Patients Treated with Natalizumab Quasispecies analysis of JC virus DNA present in urine of healthy subjects.JC virus quasispecies analysis reveals a complex viral population underlying progressive multifocal leukoencephalopathy and supports viral dissemination via the hematogenous route.JC polyomavirus attachment, entry, and trafficking: unlocking the keys to a fatal infection.Human glial chimeric mice reveal astrocytic dependence of JC virus infection An animal model for progressive multifocal leukoencephalopathy JC polyomavirus infection is strongly controlled by human leucocyte antigen class II variants Synthetic antibodies and peptides recognizing progressive multifocal leukoencephalopathy-specific point mutations in polyomavirus JC capsid viral protein 1.Frequent infection of cortical neurons by JC virus in patients with progressive multifocal leukoencephalopathy.Opportunistic DNA Recombination With Epstein-Barr Virus at Sites of Control Region Rearrangements Mediating JC Virus Neurovirulence.Human polyomavirus receptor distribution in brain parenchyma contrasts with receptor distribution in kidney and choroid plexus.JC virus promoter/enhancers contain TATA box-associated Spi-B-binding sites that support early viral gene expression in primary astrocytes.Orderly Steps in Progression of JC Virus to Virulence in the Brain.Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy Increased Prevalence of Human Polyomavirus JC Viruria in Chronic Inflammatory Rheumatic Diseases Patients in Treatment with Anti-TNF α: A 18 Month Follow-Up Study.JC Polyomavirus Infection of Primary Human Renal Epithelial Cells Is Controlled by a Type I IFN-Induced Response Changes to anti-JCV antibody levels in a Swedish national MS cohort Inhibition of JCPyV infection mediated by targeted viral genome editing using CRISPR/Cas9 Deep-Sequence Identification and Role in Virus Replication of a JC Virus Quasispecies in Patients with Progressive Multifocal Leukoencephalopathy.Immune surveillance and response to JC virus infection and PML.A case of natalizumab-associated progressive multifocal leukoencephalopathy with repeated negative CSF JCV testing.Natalizumab: risk stratification of individual patients with multiple sclerosis.Immunology of progressive multifocal leukoencephalopathy.B cells and progressive multifocal leukoencephalopathy: search for the missing link 45 years after the discovery of human polyomaviruses BK and JC: Time to speed up the understanding of associated diseases and treatment approaches.Polyomavirus detection in multiple sclerosis patients under natalizumab therapy: Profile and frequency of urinary shedding.Natalizumab treatment for multiple sclerosis: updates and considerations for safer treatment in JCV positive patients.

P2860

Q24619923-A01E7967-8CB2-42EB-AF24-032961D79CCB Q26776234-C61E4C44-4CC1-46DB-B527-2AF27F810712 Q26822247-B35F7A74-785E-4AF7-B93E-0987C38BCF64 Q26852060-01C52FDA-2105-414A-93C2-F011A74A5576 Q26859307-88EB18D3-682D-4FEC-B120-2125B157D473 Q27678593-991EC33C-9364-49B2-AE88-B3D495714EF4 Q28074684-7BDF4663-4B43-43C6-8DFC-2CAEB0DB8014 Q28552120-EC48D3B0-42A3-40C4-B5F5-5BECC96117AB Q30617802-7C79CB3C-C67B-4778-92CA-CA0A193AF62B Q34208184-32903CF5-5095-46F1-A8FE-F7228B9DC626 Q34332024-95485730-4298-4EB9-BE13-79AC94FB4276 Q34729712-AEF53B2F-931F-4890-95C4-6686A837F4F8 Q34735441-13461DE0-D612-40D6-8195-0523ED90FF98 Q34818048-B697E7BF-FC99-40E5-BC74-6F77F7A79E32 Q34963245-D4790CE2-BD3F-4D63-AA18-FC24B3DD5969 Q34991069-0FB365BD-DA69-41F6-A5FE-DD6505F4A3FD Q35033782-A71A07F4-7BA1-4381-8B49-77AD0650EDA5 Q35145401-DC8A9FFC-8203-4E56-87A4-18332C8C384F Q35145409-3D83EF2D-B2EC-4F3B-959F-FDFA77F6583F Q35157207-AC12B71A-4BB9-4520-B138-47786FB3D54F Q35602977-251165ED-EC76-4BB5-B239-F9D7F34957AE Q35634870-85189F01-A082-4AA2-A886-72D00812C67D Q35874385-3B9B2988-B7CB-4FEC-BFDE-94AB782E9824 Q35931809-A70E5AE0-EF5B-4352-93E3-30003FEA9BF2 Q35960553-EB2A9BE0-DF4B-4331-B991-78F373EB80DE Q36044561-EECBAA1C-49D7-46A0-BFAE-212C0940A3B4 Q36764988-D9D36577-568E-4A9A-A16F-20D457CAFEC9 Q36885632-9BB26791-FBC4-4D8B-A42A-CACF5082E35D Q37120268-DF8DDD76-E8F5-419D-B533-03560B126030 Q37267644-A4BF7976-FCBE-4C8E-B836-B327B42F813D Q37411994-8484114C-BDB7-4832-B3D6-71441EBAA6C6 Q37512929-9967E833-E0A0-455B-B7B4-762A27CE5565 Q37678580-848894AC-5034-4C21-B47F-275496F1E863 Q38068499-9EA157CA-905A-4CEF-96A7-36EA65D3710A Q38221343-4189BEE6-BBE3-4EAA-9700-95998311A05E Q38367755-407C63E2-113E-4153-9292-7DD8487FF1DE Q38515349-7E5FD444-A812-491A-A78C-76914DE79E78 Q38801394-E68E47E1-AF62-4591-A408-2A586960CEC7 Q39292843-EBE745C4-3171-49AE-AA27-73FF2DAEF261 Q39292858-8C595386-90A9-4796-83C3-EFF8523DAA7A

P2860

Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients.

http://www.wikidata.org/entity/Q42720362

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients.

@en

Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients.

@nl

type

label

Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients.

@en

Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients.

@nl

prefLabel

Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients.

@en

Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients.

@nl

P1433

Q42720362-62D823E9-3D8E-4228-A1AD-A0007BFC1250

P1476

Q42720362-7F03CD9F-C4E7-4308-9D99-2CCF84A8B1F3

P2093

Q42720362-039454F1-A96E-45F7-831C-A65B88500378

Q42720362-04AF2E51-D8DE-48BC-BBB9-778F04A7843A

Q42720362-054B059A-5501-4460-80E1-69CFD0B9579D

Q42720362-1DFCE934-84F7-44AB-A2DB-29136F4F2467

Q42720362-30E7074E-FECD-4C18-83B1-3B0A650D5BE9

Q42720362-347F64CF-3589-4FF6-8959-0E9AB3DFF361

Q42720362-4B29D89E-511F-4F55-B881-67055265D87B

Q42720362-51237F40-E877-42D4-AE6C-15DC51126A63

Q42720362-51F23EC2-6121-4089-B66D-954ED8BF4F63

Q42720362-8C065847-71B3-4BE2-BF6B-31D7C14D80EB

P2860

Q42720362-04CF24C0-4CE7-421D-9813-9D0EEB37BB72

Q42720362-0EABF232-E098-49F2-A7EB-DEA0452ADA37

Q42720362-19A8CB7E-76E5-45A6-B32D-1D7FC3E0C983

Q42720362-19B7D910-107E-4488-8821-AFF9BCCA6B27

Q42720362-1F67D7F7-5F52-4C70-8801-CFF30A05C240

Q42720362-2185868D-AE86-4A2E-8F92-339C620F09D8

Q42720362-23FF6C2D-33DB-4A3E-A6BC-EED0ACEC1314

Q42720362-33AC7577-D4A1-488F-BC85-BDADC61E09C7

Q42720362-374F9BC9-233A-4BA5-BB9E-AF457388CDCD

Q42720362-4C11266E-6C67-45EE-B2E3-83A33A0210D9

P304

Q42720362-854B123F-865C-4381-9819-8DD05A79725E

P31

Q42720362-2BA44A4A-8DEC-441F-9E85-DADDA4599766

P356

Q42720362-CF61C3FE-C37C-4022-B5AF-4DE2DB5B5094

P407

Q42720362-B1B9DE53-8EF6-438D-8FC0-249F847F9127

P433

Q42720362-BE5E1C11-5998-4DC8-86F9-8DB461282EB6

P478

Q42720362-910F3FC7-39D7-4C66-AC48-C49D5B0122EE

P50

Q42720362-697669B6-B38F-4114-94D2-B884E21FD435

P577

Q42720362-67AD8DC1-7FBD-4353-B3C4-6EB3E46A5744

P5875

Q42720362-4BA41678-CC00-469C-9BC2-6F2FE7C29537

P698

Q42720362-F538160A-A7B1-4621-AD12-5149FF9D7F95

P932

Q42720362-63C9D422-90C9-4A8D-A923-610DB1546203

P356

P1433

The Journal of Infectious Diseases

P1476

Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients

@en

P2093

Carl E Reid

http://www.w3.org/2001/XMLSchema#string

Gargi Sur

http://www.w3.org/2001/XMLSchema#string

Huo Li

http://www.w3.org/2001/XMLSchema#string

John P Carulli

http://www.w3.org/2001/XMLSchema#string

Kenneth Simon

http://www.w3.org/2001/XMLSchema#string

Leonid Gorelik

http://www.w3.org/2001/XMLSchema#string

Michele McAuliffe

http://www.w3.org/2001/XMLSchema#string

Paola Cinque

http://www.w3.org/2001/XMLSchema#string

Paul Carmillo

http://www.w3.org/2001/XMLSchema#string

Rich Tizard

http://www.w3.org/2001/XMLSchema#string

P2860

Seroepidemiology of human polyomaviruses

Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies

Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions.

Adaptive mutations in the JC virus protein capsid are associated with progressive multifocal leukoencephalopathy (PML)

Progressive multifocal leukoencephalopathy in HIV-1 infection.

Discrimination between sialic acid-containing receptors and pseudoreceptors regulates polyomavirus spread in the mouse

P304

237-244

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INFDIS/JIR256

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

204

http://www.w3.org/2001/XMLSchema#string

P50

Christopher J Tonkin

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51219062

http://www.w3.org/2001/XMLSchema#string

P698

21673034

http://www.w3.org/2001/XMLSchema#string

P932

3114470

http://www.w3.org/2001/XMLSchema#string